Annals On Call - SGLT2 Versus GLP1 for Cardiovascular Prevention
Authors: Robert M. Centor, Elisabetta Patorno
Journal: Annals of Internal Medicine (2021)

Web ExclusivesDecember 2021Annals On Call - SGLT2 Versus GLP1 for Cardiovascular PreventionFREERobert M. Centor, MD, Elisabetta Patorno, MD, DrPHRobert M. Centor, MDHuntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.)Search for more papers by this author, Elisabetta Patorno, MD, DrPHBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (E.P.)Search for more papers by this authorAuthor, Article and Disclosure Informationhttps://doi.org/10.7326/A20-0027 CME/MOC SectionsAboutVisual Abstract ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In this episode of Annals On Call, Dr. Centor discusses the use of sodium–glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists and the risk for cardiovascular outcomes in routine care patients with diabetes with Dr. Elisabetta Patorno.Annals articles discussed include...Sodium–Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease: https://www.acpjournals.org/doi/10.7326/M21-0893About Annals On CallAnnals On Call focuses on a clinically influential article published in Annals of Internal Medicine. Dr. Robert Centor shares his own perspective on the material and interviews topic area experts to discuss, debate, and share diverse insights about patient care and health care delivery.For more information on Annals On Call and for more episodes, visit go.annals.org/OnCall. Comments0 CommentsSign In to Submit A Comment Author, Article and Disclosure InformationAffiliations: Huntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.)Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (E.P.)Disclosures: Dr. Centor has disclosed the following: Consultancy: DynaMed, MDCalc. Employment: U.S. Department of Veterans Affairs. Dr. Patorno has reported the following: Research grants/contracts: Boehringer Ingelheim.Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Stephanie Chang, MD, MPH, Deputy Editor, reports employment with the Agency for Healthcare Research and Quality, travel compensation from the Guidelines International Network, and participation in the Patient-Centered Outcomes Research Institute methodology committee. Vineet Chopra, MD, MSc, Deputy Editor, reports grants received from the Agency for Healthcare Research and Quality and royalties from UpToDate and Oxford University Press. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interests to disclose. Eliseo Guallar, MD, MPH, DrPH, Deputy Editor, Statistics, reports that he is employed at Johns Hopkins University. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center and consultancy with Boston Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports employment with the Perelman School of Medicine, University of Pennsylvania, and consultancies with the U.S. Food and Drug Administration and the State of Colorado. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics December 2021Volume 174, Issue 12Page: OC1 ePublished: 21 December 2021 Issue Published: December 2021 CopyrightCopyright © 2021 by American College of Physicians. All Rights Reserved.Loading ...